Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Stephen Ostroff is active.

Publication


Featured researches published by Stephen Ostroff.


Proceedings of the National Academy of Sciences of the United States of America | 2011

Role of social networks in shaping disease transmission during a community outbreak of 2009 H1N1 pandemic influenza

Simon Cauchemez; Achuyt Bhattarai; Tiffany L. Marchbanks; Ryan Fagan; Stephen Ostroff; Neil M. Ferguson; David L. Swerdlow; Samir V. Sodha; Mària Moll; Frederick J. Angulo; Rakhee Palekar; W. Roodly Archer; Lyn Finelli

Evaluating the impact of different social networks on the spread of respiratory diseases has been limited by a lack of detailed data on transmission outside the household setting as well as appropriate statistical methods. Here, from data collected during a H1N1 pandemic (pdm) influenza outbreak that started in an elementary school and spread in a semirural community in Pennsylvania, we quantify how transmission of influenza is affected by social networks. We set up a transmission model for which parameters are estimated from the data via Markov chain Monte Carlo sampling. Sitting next to a case or being the playmate of a case did not significantly increase the risk of infection; but the structuring of the school into classes and grades strongly affected spread. There was evidence that boys were more likely to transmit influenza to other boys than to girls (and vice versa), which mimicked the observed assortative mixing among playmates. We also investigated the presence of abnormally high transmission occurring on specific days of the outbreak. Late closure of the school (i.e., when 27% of students already had symptoms) had no significant impact on spread. School-aged individuals (6–18 y) facilitated the introduction and spread of influenza in households, but only about one in five cases aged >18 y was infected by a school-aged household member. This analysis shows the extent to which clearly defined social networks affect influenza transmission, revealing strong between-place interactions with back-and-forth waves of transmission between the school, the community, and the household.


Clinical Infectious Diseases | 2013

Outbreak of Variant Influenza A(H3N2) Virus in the United States

Michael A. Jhung; Scott Epperson; Matthew Biggerstaff; Donna Allen; Amanda Balish; Nathelia Barnes; Amanda Beaudoin; LaShondra Berman; Sally A. Bidol; Lenee Blanton; David Blythe; Lynnette Brammer; Tiffany D'Mello; Richard N. Danila; William Davis; Sietske de Fijter; Mary DiOrio; Lizette Olga Durand; Shannon L. Emery; Brian Fowler; Rebecca Garten; Yoran Grant; Adena Greenbaum; Larisa V. Gubareva; Fiona Havers; Thomas Haupt; Jennifer House; Sherif Ibrahim; Victoria Jiang; Seema Jain

During an outbreak of H3N2v variant influenza, we identified 306 cases in ten states. Most cases reported agricultural fair attendance and/or contact with swine prior to illness. We found no evidence of efficient or sustained person-to-person transmission of H3N2v.


PLOS Currents | 2010

Seroprevalence Following the Second Wave of Pandemic 2009 H1N1 Influenza.

Ted M. Ross; Shanta M. Zimmer; Donald S. Burke; Corey J. Crevar; Donald M. Carter; James H. Stark; Brendan M. Giles; Richard K. Zimmerman; Stephen Ostroff; Bruce Y. Lee

BACKGROUND In April 2009, a new pandemic strain of influenza infected thousands of persons in Mexico and the United States and spread rapidly worldwide. During the ensuing summer months, cases ebbed in the Northern Hemisphere while the Southern Hemisphere experienced a typical influenza season dominated by the novel strain. In the fall, a second wave of pandemic H1N1 swept through the United States, peaking in most parts of the country by mid October and returning to baseline levels by early December. The objective was to determine the seroprevalence of antibodies against the pandemic 2009 H1N1 influenza strain by decade of birth among Pittsburgh-area residents. METHODS AND FINDINGS Anonymous blood samples were obtained from clinical laboratories and categorized by decade of birth from 1920-2009. Using hemagglutination-inhibition assays, approximately 100 samples per decade (n= 846) were tested from blood samples drawn on hospital and clinic patients in mid-November and early December 2009. Age specific seroprevalences against pandemic H1N1 (A/California/7/2009) were measured and compared to seroprevalences against H1N1 strains that had previously circulated in the population in 2007, 1957, and 1918. (A/Brisbane/59/2007, A/Denver/1/1957, and A/South Carolina/1/1918). Stored serum samples from healthy, young adults from 2008 were used as a control group (n=100). Seroprevalences against pandemic 2009 H1N1 influenza varied by age group, with children age 10-19 years having the highest seroprevalence (45%), and persons age 70-79 years having the lowest (5%). The baseline seroprevalence among control samples from 18-24 year-olds was 6%. Overall seroprevalence against pandemic H1N1 across all age groups was approximately 21%. CONCLUSIONS After the peak of the second wave of 2009 H1N1, HAI seroprevalence results suggest that 21% of persons in the Pittsburgh area had become infected and developed immunity. Extrapolating to the entire US population, we estimate that at least 63 million persons became infected in 2009. As was observed among clinical cases, this sero-epidemiological study revealed highest infection rates among school-age children.


PLOS ONE | 2010

Seroprevalence following the second wave of Pandemic 2009 H1N1 influenza in Pittsburgh, PA, USA.

Shanta M. Zimmer; Corey J. Crevar; Donald M. Carter; James H. Stark; Brendan M. Giles; Richard K. Zimmerman; Stephen Ostroff; Bruce Y. Lee; Donald S. Burke; Ted M. Ross

Background In April 2009, a new pandemic strain of influenza infected thousands of persons in Mexico and the United States and spread rapidly worldwide. During the ensuing summer months, cases ebbed in the Northern Hemisphere while the Southern Hemisphere experienced a typical influenza season dominated by the novel strain. In the fall, a second wave of pandemic H1N1 swept through the United States, peaking in most parts of the country by mid October and returning to baseline levels by early December. The objective was to determine the seroprevalence of antibodies against the pandemic 2009 H1N1 influenza strain by decade of birth among Pittsburgh-area residents. Methods and Findings Anonymous blood samples were obtained from clinical laboratories and categorized by decade of birth from 1920–2009. Using hemagglutination-inhibition assays, approximately 100 samples per decade (n = 846) were tested from blood samples drawn on hospital and clinic patients in mid-November and early December 2009. Age specific seroprevalences against pandemic H1N1 (A/California/7/2009) were measured and compared to seroprevalences against H1N1 strains that had previously circulated in the population in 2007, 1957, and 1918. (A/Brisbane/59/2007, A/Denver/1/1957, and A/South Carolina/1/1918). Stored serum samples from healthy, young adults from 2008 were used as a control group (n = 100). Seroprevalences against pandemic 2009 H1N1 influenza varied by age group, with children age 10–19 years having the highest seroprevalence (45%), and persons age 70–79 years having the lowest (5%). The baseline seroprevalence among control samples from 18–24 year-olds was 6%. Overall seroprevalence against pandemic H1N1 across all age groups was approximately 21%. Conclusions After the peak of the second wave of 2009 H1N1, HAI seroprevalence results suggest that 21% of persons in the Pittsburgh area had become infected and developed immunity. Extrapolating to the entire US population, we estimate that at least 63 million persons became infected in 2009. As was observed among clinical cases, this sero-epidemiological study revealed highest infection rates among school-age children.


Infection Control and Hospital Epidemiology | 1993

A nosocomial pseudo-outbreak of Mycobacterium xenopi due to a contaminated potable water supply: lessons in prevention.

David H. Sniadack; Stephen Ostroff; Michael A. Karlix; Ronald W. Smithwick; Benjamin Schwartz; Mary Ann Sprauer; Vella A. Silcox; Robert C. Good

OBJECTIVES To determine risk factors for Mycobacterium xenopi isolation in patients following a pseudo-outbreak of infection with the organism. DESIGN Retrospective cohort analysis of mycobacteriology laboratory specimen records and frequency-matched case-control study of hospital patients. SETTING General community hospital. PATIENTS For the case-control study, 13 case patients and 39 randomly selected controls with mycobacterial cultures negative for M xenopi, frequency matched by specimen source, whose specimens were submitted from June 1990 through June 1991. RESULTS Between June 1990 and June 1991, M xenopi was isolated from 13 clinical specimens processed at a midwestern hospital, including sputum (n = 6), bronchial washings (2), urine (4), and stool (1). None of the patients with M xenopi-positive specimens had apparent mycobacterial disease, although five received antituberculosis drug therapy for a range of one to six months. Specimens collected in a nonsterile manner were more likely to grow the organism than those collected aseptically (3.1% versus 0, relative risk = infinity, P = 0.003). M xenopi isolation was attributed to exposure of clinical specimens to tap water, including rinsing of bronchoscopes with tap water after disinfection, irrigation with tap water during colonoscopy, gargling with tap water before sputum collection, and collecting urine in recently rinsed bedpans. M xenopi was isolated from tap water in 20 of 24 patient rooms tested, the endoscopy suite, and the central hot water mixing tank, but not from water in the microbiology laboratory. The pseudo-outbreak occurred following a decrease in the hot water temperature from 130 degrees F to 120 degrees F in 1989. CONCLUSIONS Maintenance of a higher water temperature and improved specimen collection protocols and instrument disinfection procedures probably would have prevented this pseudo-outbreak.


Clinical Infectious Diseases | 2013

Campylobacter jejuni Infections Associated With Unpasteurized Milk—Multiple States, 2012

Allison H. Longenberger; Aimee Palumbo; Alvina K. Chu; Mària Moll; Andre Weltman; Stephen Ostroff

In 2012, a multistate outbreak of Campylobacter infections associated with unpasteurized milk resulted in 148 illnesses. A dairy with a Pennsylvania Department of Agriculture unpasteurized milk permit and minimal deficiencies identified during inspection was the outbreak source, demonstrating the ongoing hazards of unpasteurized dairy products.


Clinical Infectious Diseases | 2011

Viral Shedding Duration of Pandemic Influenza A H1N1 Virus during an Elementary School Outbreak—Pennsylvania, May–June 2009

Achuyt Bhattarai; Julie Villanueva; Rakhee Palekar; Ryan Fagan; Wendy Sessions; Jorn Winter; LaShondra Berman; James R. Lute; Rebecca Leap; Tiffany L. Marchbanks; Samir V. Sodha; Mària Moll; Xiyan Xu; Alicia M. Fry; Anthony E. Fiore; Stephen Ostroff; David L. Swerdlow

We report shedding duration of 2009 pandemic influenza A (pH1N1) virus from a school-associated outbreak in Pennsylvania during May through June 2009. Outbreak-associated students or household contacts with influenza-like illness (ILI) onset within 7 days of interview were recruited. Nasopharyngeal specimens, collected every 48 hours until 2 consecutive nonpositive tests, underwent real-time reverse transcriptase polymerase chain reaction (rRT-PCR) and culture for pH1N1 virus. Culture-positive specimens underwent virus titrations. Twenty-six (median age, 8 years) rRT-PCR-positive persons, for pH1N1 virus, were included in analysis. Median shedding duration from fever onset by rRT-PCR was 6 days (range, 1-13) and 5 days (range, 1-7) by culture. Following fever resolution virus was isolated for a median of 2 days (range, 0-5). Highest and lowest virus titers detected, 2 and 5 days following fever onset, were 3.2 and 1.2 log(10) TCID(50)/mL respectively. Overall, shedding duration in children and adults were similar to seasonal influenza viruses.


PLOS ONE | 2013

A comparison of non-typhoidal Salmonella from humans and food animals using pulsed-field gel electrophoresis and antimicrobial susceptibility patterns.

Carol H. Sandt; Paula J. Fedorka-Cray; Deepanker Tewari; Stephen Ostroff; Kevin Joyce; Nkuchia M. M’ikanatha

Salmonellosis is one of the most important foodborne diseases affecting humans. To characterize the relationship between Salmonella causing human infections and their food animal reservoirs, we compared pulsed-field gel electrophoresis (PFGE) and antimicrobial susceptibility patterns of non-typhoidal Salmonella isolated from ill humans in Pennsylvania and from food animals before retail. Human clinical isolates were received from 2005 through 2011 during routine public health operations in Pennsylvania. Isolates from cattle, chickens, swine and turkeys were recovered during the same period from federally inspected slaughter and processing facilities in the northeastern United States. We found that subtyping Salmonella isolates by PFGE revealed differences in antimicrobial susceptibility patterns and, for human Salmonella, differences in sources and invasiveness that were not evident from serotyping alone. Sixteen of the 20 most common human Salmonella PFGE patterns were identified in Salmonella recovered from food animals. The most common human Salmonella PFGE pattern, Enteritidis pattern JEGX01.0004 (JEGX01.0003ARS), was associated with more cases of invasive salmonellosis than all other patterns. In food animals, this pattern was almost exclusively (99%) found in Salmonella recovered from chickens and was present in poultry meat in every year of the study. Enteritidis pattern JEGX01.0004 (JEGX01.0003ARS) was associated with susceptibility to all antimicrobial agents tested in 94.7% of human and 97.2% of food animal Salmonella isolates. In contrast, multidrug resistance (resistance to three or more classes of antimicrobial agents) was observed in five PFGE patterns. Typhimurium patterns JPXX01.0003 (JPXX01.0003 ARS) and JPXX01.0018 (JPXX01.0002 ARS), considered together, were associated with resistance to five or more classes of antimicrobial agents: ampicillin, chloramphenicol, streptomycin, sulfonamides and tetracycline (ACSSuT), in 92% of human and 80% of food animal Salmonella isolates. The information from our study can assist in source attribution, outbreak investigations, and tailoring of interventions to maximize their impact on prevention.


Clinical Infectious Diseases | 2011

An Outbreak of 2009 Pandemic Influenza A (H1N1) Virus Infection in an Elementary School in Pennsylvania

Tiffany L. Marchbanks; Achuyt Bhattarai; Ryan Fagan; Stephen Ostroff; Samir V. Sodha; Mària Moll; Bruce Y. Lee; Chung-Chou H. Chang; Brent Ennis; Phyllis H. Britz; Anthony E. Fiore; Michael Nguyen; Rakhee Palekar; W. Roodly Archer; Thomas L. Gift; Rebecca Leap; Benjamin Nygren; Simon Cauchemez; Frederick J. Angulo; David L. Swerdlow

In May 2009, one of the earliest outbreaks of 2009 pandemic influenza A virus (pH1N1) infection resulted in the closure of a semi-rural Pennsylvania elementary school. Two sequential telephone surveys were administered to 1345 students (85% of the students enrolled in the school) and household members in 313 households to collect data on influenza-like illness (ILI). A total of 167 persons (12.4%) among those in the surveyed households, including 93 (24.0%) of the School A students, reported ILI. Students were 3.1 times more likely than were other household members to develop ILI (95% confidence interval [CI], 2.3-4.1). Fourth-grade students were more likely to be affected than were students in other grades (relative risk, 2.2; 95% CI, 1.2-3.9). pH1N1 was confirmed in 26 (72.2%) of the individuals tested by real-time reverse-transcriptase polymerase chain reaction. The outbreak did not resume upon the reopening of the school after the 7-day closure. This investigation found that pH1N1 outbreaks at schools can have substantial attack rates; however, grades and classrooms are affected variably. Additional study is warranted to determine the effectiveness of school closure during outbreaks.


Infection Control and Hospital Epidemiology | 1993

State regulation of hospital water temperature

Adam S. Mandel; Mary Ann Sprauer; David H. Sniadack; Stephen Ostroff

OBJECTIVE The purpose of this study was to determine current regulations and policies in the United States concerning maximal water temperatures in acute care hospitals. DESIGN A standardized questionnaire administered by telephone to health department officials from 50 states and the District of Columbia. SETTING State Health Departments in the 50 states and the District of Columbia. RESULTS All states responded to the survey. Respondents from 39 states (77%) reported regulating maximum allowable hospital water temperature at a mean of 116 degrees F (median, 120 degrees F; mode 110 degrees F; range, 110 degrees F to 129 degrees F). Twelve states (23%) have no regulations for maximum water temperature. Of the 39 states regulating maximum water temperature, 30 (77%) routinely monitor hospital compliance. Nine states (23%) conduct inspections only in response to a complaint or incident. CONCLUSIONS There is great variation among the states with respect to the existence, enforcement, and specific regulations controlling hospital water temperature. Risk-benefit and cost-effectiveness analyses would help to assess the risk of scald injuries at water temperatures that will inhibit microbial contamination.

Collaboration


Dive into the Stephen Ostroff's collaboration.

Top Co-Authors

Avatar

Mària Moll

Pennsylvania Department of Health

View shared research outputs
Top Co-Authors

Avatar

David L. Swerdlow

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Achuyt Bhattarai

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Rakhee Palekar

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Ryan Fagan

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Samir V. Sodha

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Tiffany L. Marchbanks

Pennsylvania Department of Health

View shared research outputs
Top Co-Authors

Avatar

Bruce Y. Lee

Johns Hopkins University

View shared research outputs
Researchain Logo
Decentralizing Knowledge